Robert I. Blum

Robert I. Blum

Principal Executive OfficeratCytokinetics· In proxies 2021–2025

Pay in FY2025Cytokinetics stock +35.1% the same year

Robert I. Blum was paid $11.9M in FY2025 (Dec). Cytokinetics stock rose 35.1% that year.

Pay$100 in the stock at the end of FY20 → $543
Pay is from the Summary Compensation Table of each Cytokinetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CytokineticsPublic company · 5 yr
    • Principal Executive Officer2021 – Present · 5 yrStock in role +193%
  2. Gamida Cell Ltd.Public company · 5 yr
    • Director2018 – 2023 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?